70487--3/31/2009--NATIONAL_RESEARCH_CORP

related topics
{system, service, information}
{stock, price, operating}
{regulation, government, change}
{customer, product, revenue}
{competitive, industry, competition}
{acquisition, growth, future}
{personnel, key, retain}
{property, intellectual, protect}
{product, candidate, development}
We depend on performance tracking contract renewals for a large share of our revenue and our operating results could be adversely affected. Our operating results may fluctuate on a quarterly basis, and this may cause our stock price to decline. We operate in a highly competitive market and we could experience increased price pressure and expenses as a result. Because our clients are concentrated in the healthcare industry, our revenue and operating results may be adversely affected by a business downturn or consolidation with respect to the healthcare industry. Our future success depends on our ability to manage our growth, including identifying acquisition candidates and effectively integrating acquired companies. We face several risks relating to our ability to collect the data on which our business relies. Our principal shareholder effectively controls our company. Our business and operating results could be adversely affected if we are unable to attract or retain key managers and other personnel. If intellectual property and other proprietary information technology were copied or independently developed by our competitors, our operating results could be negatively affected. Errors in, or dissatisfaction with, performance tracking and other surveys could adversely affect our business. Regulatory developments could adversely affect our revenue and results of operations.

Full 10-K form ▸

related documents
1008586--4/10/2006--LANVISION_SYSTEMS_INC
225628--1/29/2008--MEGADATA_CORP
1047202--3/9/2006--GETTY_IMAGES_INC
1040130--6/1/2010--PETMED_EXPRESS_INC
1040130--6/1/2009--PETMED_EXPRESS_INC
1042173--3/8/2007--SCIENTIFIC_LEARNING_CORP
1085653--4/2/2007--ECOLLEGE_COM
949589--3/2/2006--INVESTORS_FINANCIAL_SERVICES_CORP
1040130--6/3/2008--PETMED_EXPRESS_INC
708850--8/29/2007--DIONEX_CORP_/DE
1050031--3/14/2007--SM&A
1361658--2/29/2008--WYNDHAM_WORLDWIDE_CORP
1042173--3/11/2008--SCIENTIFIC_LEARNING_CORP
1010612--3/14/2006--SYKES_ENTERPRISES_INC
1316360--1/24/2006--IHS_Inc.
1316360--1/24/2008--IHS_Inc.
1040792--3/29/2006--A_CONSULTING_TEAM_INC
34782--3/3/2006--1ST_SOURCE_CORP
1042173--3/5/2009--SCIENTIFIC_LEARNING_CORP
946356--3/9/2007--OAKLEY_INC
768408--6/25/2009--CYANOTECH_CORP
850483--4/2/2007--GTSI_CORP
1057379--3/14/2007--ANSWERTHINK_INC
1085320--3/31/2006--MUZAK_HOLDINGS_LLC
1085319--3/31/2006--MUZAK_HOLDINGS_LLC
1085320--4/2/2007--MUZAK_HOLDINGS_LLC
1085319--4/2/2007--MUZAK_HOLDINGS_LLC
109198--3/31/2009--TJX_COMPANIES_INC_/DE/
1037417--12/24/2008--IFTH_ACQUISITION_CORP
807884--2/29/2008--CASH_AMERICA_INTERNATIONAL_INC